Sanofi SA (EPA: SAN) received a number of ratings updates from brokerages and research firms in the last week:

  • Sanofi SA had its “buy” rating reaffirmed by analysts at Natixis. They now have a $106.49 (€82) price target on the stock.
  • Sanofi SA had its “outperform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a $100.00 (€77) price target on the stock.
  • Sanofi SA had its “buy” rating reaffirmed by analysts at Societe Generale. They now have a $106.49 (€82) price target on the stock.
  • Sanofi SA had its “outperform” rating reaffirmed by analysts at CA Cheuvreux. They now have a $100.00 (€77) price target on the stock.
  • Sanofi SA had its “overweight” rating reaffirmed by analysts at JPMorgan Chase. They now have a $100.00 (€77) price target on the stock.

Shares of Sanofi SA opened at 69.30 on Wednesday. Sanofi SA has a one year low of €47.00 and a one year high of €69.86. The company has a market cap of €91.320 billion and a P/E ratio of 15.35.

Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.